Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.715 USD | +4.35% | +5.10% | +600.65% |
05-14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
05-02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+600.65% | 195M | |
+5.99% | 111B | |
+11.58% | 106B | |
-12.67% | 22.24B | |
+0.12% | 21.25B | |
-5.06% | 18.97B | |
-35.21% | 18.52B | |
-11.45% | 16.81B | |
+38.07% | 12.54B | |
-24.65% | 8.09B |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- Elevation Oncology Expands Phase 1 Study of Potential Solid Tumor Treatment